Adverse Effects of High-Dose Olanzapine in Treatment-Refractory Schizophrenia
Authors:
- Brian D. BronsonBBBrian D. Bronson
- Jean-Pierre LindenmayerJLJean-Pierre Lindenmayer
- 1 June 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 20 (3) , 382-384
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Novel antipsychotics and new onset diabetesBiological Psychiatry, 1998
- 5-HT2and D2Receptor Occupancy of Olanzapine in Schizophrenia: A PET InvestigationAmerican Journal of Psychiatry, 1998
- High-Dose Olanzapine for Treatment-Refractory SchizophreniaAmerican Journal of Psychiatry, 1997
- The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrationsSchizophrenia Research, 1997
- Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trialAmerican Journal of Psychiatry, 1997
- Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trialPsychopharmacology, 1996
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989